Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jan 1, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS; Respiratory tract infection NOS; Ketonuria; Death by ... | Euthanized |
| Jan 1, 2025 | Cat | Cat (unknown) | Cyclosporine | Unclassifiable adverse event | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Soft stool; Weight loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Molidustat | Vomiting | Recovered/Normal |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Elevated temperature | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Scratching; Grooming disorder | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (other) | Selamectin | Diarrhoea | Outcome Unknown |
| Jan 1, 2025 | Cat | Maine Coon | Fluralaner/Moxidectin Spot-On | Application site hair loss; Application site scab; Drug administered at inapp... | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Weight loss; Vomiting; Enlarged thyroid gland; Distress; UNPALATABLE | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Robenacoxib | Diarrhoea; Increased respiratory rate; Inappropriate urination; Licking; Inap... | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Death | Died |
| Jan 1, 2025 | Cat | Domestic Longhair | Cyclosporine | Renal disorder NOS; Non-regenerative anaemia | Recovered/Normal |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Anorexia | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Ketosis; Lack of efficacy - NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Crossbred Feline/cat | Selamectin;Sarolaner | Application site hair loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Dilated pupils; Hiding; Unresponsive to stimuli; Not eating; Death; Pacing; N... | Died |
| Jan 1, 2025 | Cat | Domestic Shorthair | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Lethargy (see also Central nervous system depression in Neurological); Not ea... | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (other) | Tiletamine Hcl;Zolazapam Hcl | Death; Underdose | Died |
| Jan 1, 2025 | Cat | Domestic Shorthair | Selamectin | Lack of efficacy (endoparasite) - tapeworm; Lack of efficacy (endoparasite) -... | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Praziquantel | Vomiting; Lack of efficacy (endoparasite) - tapeworm; Product label issues | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Maropitant Citrate | Sleepiness - systemic disorder; Intentional misuse | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Unwell | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Soft stool; Arthritis; Hyperglycaemia; Inappropriate defecation; Ketosis; Lac... | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Hallucination; Not eating; Not drinking; Not defecating; Not urinating | Recovered/Normal |
| Jan 1, 2025 | Cat | Domestic Shorthair | Spinosad; Milbemycin Oxime | Hyperglycaemia; Collapse NOS (see also Cardio-vascular and Neurological disor... | Died |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Hyperphosphataemia; Other abnormal test result NOS; Elevated blood urea nitro... | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Nitenpyram | Dyspnoea; Mydriasis; Nervous; Lethargy (see also Central nervous system depre... | Recovered/Normal |
| Jan 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Scratching; Wound; Alopecia; Crust | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss; Distension of abdomen; Poor coat condition; Lack of efficacy - NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Praziquantel; Emodepside | Death | Died |
| Jan 1, 2025 | Cat | Cat (other) | Frunevetmab | Allergy NOS; Pinnal reddening; Scratching | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Dermatitis | Outcome Unknown |
| Jan 1, 2025 | Cat | American Curl Shorthair | Selamectin | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Pradofloxacin | Diarrhoea | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Selamectin | Lack of efficacy (endoparasite) - tapeworm; Lack of efficacy (endoparasite) -... | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Diabetic ketoacidosis | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (other) | Frunevetmab | General illness; Death | Died |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Death | Died |
| Jan 1, 2025 | Cat | Domestic Shorthair | Mirtazapine | Application site skin discolouration; Application site crust; Application sit... | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Lethargy (see also Central nervous system depression in Neurological); Anorex... | Ongoing |
| Jan 1, 2025 | Cat | Domestic Longhair | Frunevetmab | Respiratory tract disorder NOS | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Orbiflox/Momet/Posaco Eardrops | Application site pustule | Ongoing |
| Jan 1, 2025 | Cat | Cat (other) | Frunevetmab | Death | Died |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Hallucination | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Sedation | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Other abnormal test result NOS; Application site hair loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Elevated temperature | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Ear infection NOS; Excessive ear wax; Head shake - ear disorder | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Aggression; Biting -aggression (see also Skin and appendages disorders) | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.